Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14,301 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Molecular determinants of LXRalpha agonism.
Wang M, Thomas J, Burris TP, Schkeryantz J, Michael LF. Wang M, et al. Among authors: thomas j. J Mol Graph Model. 2003 Nov;22(2):173-81. doi: 10.1016/S1093-3263(03)00159-1. J Mol Graph Model. 2003. PMID: 12932788
A natural product ligand of the oxysterol receptor, liver X receptor.
Bramlett KS, Houck KA, Borchert KM, Dowless MS, Kulanthaivel P, Zhang Y, Beyer TP, Schmidt R, Thomas JS, Michael LF, Barr R, Montrose C, Eacho PI, Cao G, Burris TP. Bramlett KS, et al. J Pharmacol Exp Ther. 2003 Oct;307(1):291-6. doi: 10.1124/jpet.103.052852. Epub 2003 Jul 31. J Pharmacol Exp Ther. 2003. PMID: 12893846
T0901317 is a dual LXR/FXR agonist.
Houck KA, Borchert KM, Hepler CD, Thomas JS, Bramlett KS, Michael LF, Burris TP. Houck KA, et al. Mol Genet Metab. 2004 Sep-Oct;83(1-2):184-7. doi: 10.1016/j.ymgme.2004.07.007. Mol Genet Metab. 2004. PMID: 15464433
Differences in the effectiveness of individual-level smoking cessation interventions by socioeconomic status.
Theodoulou A, Fanshawe TR, Leavens E, Theodoulou E, Wu AD, Heath L, Stewart C, Nollen N, Ahluwalia JS, Butler AR, Hajizadeh A, Thomas J, Lindson N, Hartmann-Boyce J. Theodoulou A, et al. Among authors: thomas j. Cochrane Database Syst Rev. 2025 Jan 27;1:CD015120. doi: 10.1002/14651858.CD015120.pub2. Cochrane Database Syst Rev. 2025. PMID: 39868569 Review.
Characterization of Hospital Admissions During Immune Checkpoint Inhibitor Therapy: Insights From the ICOG Study.
Wiegmann JP, Fröhlich T, Möhn N, Duzzi L, Narten E, Aurich J, Thomas J, Grote-Levi L, Mahjoub S, Berliner D, Wirth T, Golpon H, Bollmann BA, Von Wasilewski I, Gutzmer R, Heidel FH, Skripuletz T, Beutel G, Ivanyi P; ICOG‐CCCH (Immune Cooperative Oncology Group, Comprehensive Cancer Center Hannover). Wiegmann JP, et al. Among authors: thomas j. Cancer Med. 2025 Feb;14(3):e70582. doi: 10.1002/cam4.70582. Cancer Med. 2025. PMID: 39865401 Free article.
14,301 results
You have reached the last available page of results. Please see the User Guide for more information.